Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Group, mentioned her commerce group “will use each device out there — together with authorized motion if needed — to battle this dangerous overseas value management scheme.”
Trump in July gave the drug business a one-month deadline to provide you with another plan. However pharmaceutical firms refused to meet with the president and the deadline handed.
An business different delivered to the White Home in late August would have saved the federal government and seniors significantly less money however might even have been applied earlier than the election and assist Trump ship on a signature promise in his 2016 marketing campaign.
However talks between PhRMA and the White Home broke down final week, in response to two lobbyists.
Susannah Luthi and Dan Diamond contributed to this report.